Jordanian health officials say monkeypox is a low threat for their country

Monkeypox poses a low risk to public health in Jordan, according to an infectious diseases official, but officials have been more attentive since the coronavirus.

Many European and North American countries have recently reported cases of smallpox-related sickness. There have been no cases reported in Jordan, a country with a population of  about 10 million, during the current outbreak.

Despite the lack of confirmed instances, Raeda Kutub, the director of Jordan's CDC (Center for Contagious Diseases) told state television that the country's testing capabilities aren't up to par yet.

The country's major public laboratory will soon be able to test for monkeypox, which produces fever, chills, rash, and lesions, according to Ms Kutub.

In spite of its lethal nature, the monkeypox virus does not spread quickly, she noted.

As many as one in 10 individuals are estimated to die from smallpox, however vaccinations are available and antiviral medications are under development.

Only 45 percent of Jordan's population have received complete vaccination for COVID-19 virus, according to Ms Kutub.

"There's no need to freak out," she insisted. A lesson from the coronavirus is that we need to respond quickly to any change, and we're on high alert. "

"Our data will have to be accurate and in accordance with international standards if we register any cases."

In Jordan, over 1.7 million instances of coronavirus have already been reported, with 14,066 deaths from the disease officially documented.

Many PCR testing facilities in Jordan will close in 2022 due to a lack of demand and the elimination of testing requirements, as Jordanian authorities stopped providing daily coronavirus statistics last year.

The infection figures were at 300 during the week of May 7-13, according to Ministry of Health data.